CEPI: Achieving an unprecedented acceleration of vaccine development and global manufacturing capacity to prevent COVID-19.

May 27, 2020, 12:37 PM by Melodi Moore

CEPI announces a funding opportunity for the rapid development of vaccines against COVID-19. This document describes the scope, requirements and processes for submission.

The objective of this Call for Proposals is to support the rapid development of vaccines with a goal of achieving licensure/emergency authorization in 12-18 months or less and to ensure the availability of sufficient doses for wide-spread global deployment as soon as possible in 2021. This call is being issued in conjunction with the establishment of the Access to COVID-19 Tools (ACT) Accelerator (https://www.who.int/who-documents-detail/access-to-covid-19-tools-(act)-accelerator), a public-private partnership committed to speeding the development of and global access to diagnostics, therapeutics, and vaccines.

Deadline: June 30, 2020

Welcome to the UTMB Research Resources Blog

Sponsored by Research Services, the blog is set up to assist the UTMB research community by disseminating information from various sources in one reliable, relatable and easy to locate place. Users will be able to find updates from NIH, UT System and UTMB as well as special events and lectures taking place at the University, Galveston and in the area. Available funding opportunities are also included and in most cases broken down by career level for convenience and searching ease.

The blog is designed to be an interactive tool for researchers at all levels. Readers are encouraged to comment, suggest topics and forward ideas.

Please visit the Research Resources Blog often. To receive updates of all blog articles, please join the UTMB Research Community Team. Once there, you can also join the channels you feel would benefit you most.